Age, Biography and Wiki
Mads Krogsgaard Thomsen was born on 19 December, 0060, is a businessperson. Discover Mads Krogsgaard Thomsen's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 63 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
N/A |
| Zodiac Sign |
Sagittarius |
| Born |
19 December, 1960 |
| Birthday |
19 December |
| Birthplace |
N/A |
| Nationality |
|
We recommend you to check the complete list of Famous People born on 19 December.
He is a member of famous businessperson with the age years old group.
Mads Krogsgaard Thomsen Height, Weight & Measurements
At years old, Mads Krogsgaard Thomsen height not available right now. We will update Mads Krogsgaard Thomsen's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Mads Krogsgaard Thomsen Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Mads Krogsgaard Thomsen worth at the age of years old? Mads Krogsgaard Thomsen’s income source is mostly from being a successful businessperson. He is from . We have estimated
Mads Krogsgaard Thomsen's net worth
, money, salary, income, and assets.
| Net Worth in 2023 |
$1 Million - $5 Million |
| Salary in 2023 |
Under Review |
| Net Worth in 2022 |
Pending |
| Salary in 2022 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
businessperson |
Mads Krogsgaard Thomsen Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Mads Krogsgaard Thomsen was employed by Novo Nordisk in 1991 as head of Growth Hormone Research and became Executive Vice President for Diabetes R&D in 1994. In November 2000 he was appointed executive vice president and Chief Scientific Officer (CSO). From 1994 to 2021 he was responsible for the research and development of 20 medical products especially within diabetes treatment and the groundbreaking development of GLP-1 and tablet technology used as replacement for conventional injection-based technology in biological diabetes treatment. Mads Krogsgaard Thomsen left the position as Senior Vice President o R&D on February 28 in 2021 for the position as CEO of the Novo Nordisk Foundation where he replaced Birgitte Nauntofte. He took over the role as CEO on March 1, 2021.
From 2017 to 2019, Thomsen was the chairman of the board of directors at University of Copenhagen.
Mads Krogsgaard Thomsen went to boarding school in Epsom, Surrey in Great Britain from 1967 to 1971. He graduated from highschool from Rungsted Statsskole in 1979. He holds a master's degree from The Royal Veterinary and Agricultural University from 1986, now part of the University of Copenhagen. According to Krogsgaard Thomsen himself, he originally wanted to be a practicing veterinarian, and was inspired by the British television series All Creatures Great And Small. At the Royal Veterinary and Agricultural University, however, he started to take an interest in pursuing a career in either science or the pharmaceutical industry. He finished his PhD. from the same university in 1991.
Mads Krogsgaard Thomsen (born December 27, 1960) is a Danish businessman, CEO of the Novo Nordisk Foundation and former Executive Vice President of Research & Development, head of R&D and Chief Scientific Officer (CSO) at the pharmaceutical company Novo Nordisk. He was appointed senior vice president of Diabetes R&D in 1994 and in November 2000 he was appointed executive vice president and chief science officer.
